Drug Type Small molecule drug |
Synonyms Tefinostat tartrate, CHR-2845 |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H37N3O5 |
InChIKeyGLNWREBYRLDPQP-MHZLTWQESA-N |
CAS Registry914382-60-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 2 | GB | 01 Jan 2013 | |
Inflammation | Phase 2 | GB | 29 Jul 2012 | |
Chronic Myelomonocytic Leukemia | Phase 2 | GB | - | |
Philadelphia chromosome positive chronic myelogenous leukemia | Phase 2 | - | - | |
Cutaneous T-Cell Lymphoma | Phase 1 | BE | 01 Dec 2008 | |
Cutaneous T-Cell Lymphoma | Phase 1 | FR | 01 Dec 2008 | |
Cutaneous T-Cell Lymphoma | Phase 1 | NL | 01 Dec 2008 |